Research work · 2017
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry, Bruno Sangro, Thomas C. C. Yau
The Lancet
Research work · 2017
Anthony B. El-Khoueiry, Bruno Sangro, Thomas C. C. Yau
The Lancet